chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red swollen sight from injection. These listed reactions took place within 4-5 hours of injection, and on the third day, I am just starting to be better. Severe headache, Body aches. Loss of appetite. Low grade fever. Fatigue.
Per Alert, patient was given second dose too early. First dose was on 1/04/2022 and 2nd dose was on 1/20/2022. Alert says "NOT VALID" on 2nd dose.
Got the DTaP and Heb B shots around 10:00 AM, son had a mild cold with no fever. Later in the afternoon to early evening my son was very irritable and felt slightly warm. I gave him Tylenol around 5 pm. We went to bed around 8 pm. I woke around 2 am because my son's body was so hot it woke me up. Our thermometer is very unreliable but he got more Tylenol and husband went to store for a new thermometer. About 1 hour after Tylenol his temperature was 101. In the morning my son was not his usual happy self. He usually greets anyone (especially cashiers) with a giant smile. Instead he just stared lethargically. He was very irritable and clingy all day. Fever present at all times, temp depended on how recently he got Tylenol or Motrin and how much he managed to spit out. It is now 6:30 am on 12/18/2014 and he's puked a tiny bit this morning, still has a raging fever and is absolutely miserable. He cries any time we aren't laying down in bed together, with my breast out and available to him if he needs to nurse and/or cuddle.
rash all over back, spread to all over trunk, face, arms, chest;30OCT still have some rash on face-very itchy & uncomfortable;
numness in her legs and arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numness in her legs and arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numness in her legs and arm). At the time of the report, HYPOAESTHESIA (numness in her legs and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not provided. Treatment information was not provided.
Social problem; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in an adult patients who received Herpes zoster (Shingrix) for an unknown indication.   Previously administered products included Shingrix (received 1st dose on an unknown ).   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. The action taken with Shingrix was unknown. On an unknown date, the outcome of the social problem was unknown.  Additional details were received as follows: The age at vaccination was no applicable for this report.  The patient reported that a number of her patients would not be able to receive the second dose of Shingrix within six months after dose 1 due to the SARS-CoV-19 outbreak.
High fever; muscle aches; extreme lethargy continuing a month; early menstrual cycle (two weeks early); swollen lymph nodes in my armpit; ringing that comes and goes in my left ear; This is a spontaneous report from a contactable consumer or other non-hcp (patient). A 30-years-old non-pregnant female patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0183), via an unspecified route of administration, in left arm on 19May2021 12:00 (age at the time of vaccination 30-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, in left arm on 28Apr2021 12:00 (age at the time of vaccination 30-years-old), as a single dose for COVID-19 immunization. The patient had no known allergies. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. No treatment required. On 19May2021 12:00, patient experienced High fever, muscle aches, extreme lethargy continuing a month, early menstrual cycle (two weeks early), swollen lymph nodes in my armpit, and ringing that comes and goes in my left ear. Adverse event resulted in doctor or other healthcare professional office/clinic visit. No treatment required. The outcome for all the events was not recovered.  Follow-up (19Jul2021): Follow-up attempts completed. No further information expected.
"Eye pain", headache and neck soreness starting last night, took Tylenol and using eye drops for symptoms. Denies any other symptoms.
So painful that she could hardly touch her arm; Patient has to stop everything she's doing / can't do anything though it doesn't last long; Pain is also getting sooner than later, more often than before , almost everyday; Severe pain in her left side where she got the shot; Pain in the middle of her upper arm, in the inside muscle like if someone was twisting the muscles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (So painful that she could hardly touch her arm), MOBILITY DECREASED (Patient has to stop everything she's doing / can't do anything though it doesn't last long), CONDITION AGGRAVATED (Pain is also getting sooner than later, more often than before , almost everyday), VACCINATION SITE PAIN (Severe pain in her left side where she got the shot) and MYALGIA (Pain in the middle of her upper arm, in the inside muscle like if someone was twisting the muscles) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (So painful that she could hardly touch her arm), MOBILITY DECREASED (Patient has to stop everything she's doing / can't do anything though it doesn't last long), CONDITION AGGRAVATED (Pain is also getting sooner than later, more often than before , almost everyday), VACCINATION SITE PAIN (Severe pain in her left side where she got the shot) and MYALGIA (Pain in the middle of her upper arm, in the inside muscle like if someone was twisting the muscles). At the time of the report, PAIN IN EXTREMITY (So painful that she could hardly touch her arm), MOBILITY DECREASED (Patient has to stop everything she's doing / can't do anything though it doesn't last long), CONDITION AGGRAVATED (Pain is also getting sooner than later, more often than before , almost everyday), VACCINATION SITE PAIN (Severe pain in her left side where she got the shot) and MYALGIA (Pain in the middle of her upper arm, in the inside muscle like if someone was twisting the muscles) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were provided.   Patient has not taken any medication for the pain as it comes in short episodes and last a few seconds.   This case was linked to MOD-2021-305118 (Patient Link).
Severe Headache; Migraine; Body aches; Fever; Chills; Extreme Fatigue; Sore Throat; Congestion; This is a spontaneous report from a contactable other HCP (patient). A 49-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular on left arm, on 23Dec2020 08:30 at single dose for COVID-19 immunization. There was no medical history, no known allergies. The patient was not allergic to medications, food, or other products. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No any other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. The patient experienced severe headache, migraine, body aches, fever, chills, extreme fatigue, sore throat, congestion on 24Dec2020 04:00. AEs resulted in doctor or other healthcare professional office/clinic visit. No treatment received for AE. Events outcome was not recovered.  Information on the lot/batch number has been requested.
soreness, flu-like symptoms, headache, and body aches; soreness, flu-like symptoms, headache, and body aches; soreness, flu-like symptoms, headache, and body aches; muscle pull; This is a spontaneous report from a contactable female consumer. A female patient with unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 04Feb2021 at 8 am as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient received first dose of vaccine on an unspecified date. On an unspecified date after the vaccination, the patient experienced side effects such as soreness, flu-like symptoms, headache, body aches and muscle pull. She states at 08:30PM, the caller took Tylenol for a muscle pull that was not from the shot, but from doing an exercise class. later that night, she didn't feel too good, so she took another Tylenol. She states that she is hearing that people should not take Tylenol or Advil with the COVID Shot. Caller is wondering what information is available on this. she just wants to know if her product will be effective now that she took Tylenol. She also asked, if she should give her flu-like symptoms, headache, and body aches a day or two before they go away after receiving both doses of Pfizer's COVID vaccine. Treatment taken includes Tylenol. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Administered PNEUMOVAX on 11/7/15 - pt states pain localized at site of left deltoid only - denies swelling or redness. Today pt states pain continues to radiate down arm - had pain under arm, breast.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium
Having ideation (suicidal) thoughts; Had no energy; Kept falling asleep at work, and almost fell asleep while driving to and from work; This spontaneous case was reported by a consumer and describes the occurrence of SUICIDAL IDEATION (Having ideation (suicidal) thoughts) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A and 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Thyroid disorder.   On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Oct-2021, the patient experienced SUICIDAL IDEATION (Having ideation (suicidal) thoughts) (seriousness criterion medically significant). 23-Oct-2021, the patient experienced ASTHENIA (Had no energy) and SOMNOLENCE (Kept falling asleep at work, and almost fell asleep while driving to and from work). At the time of the report, SUICIDAL IDEATION (Having ideation (suicidal) thoughts), ASTHENIA (Had no energy) and SOMNOLENCE (Kept falling asleep at work, and almost fell asleep while driving to and from work) outcome was unknown.            Patient stated that she saw her therapist on 25-Oct-2021 as she was having ideation (suicidal) thoughts. Patient stated that her physician knows about her adverse events. Concomitant medications include unspecified blood pressure and unspecified thyroid medications.  No treatment medications were reported.  Company Comment: This case concerns a  62-year-old, female patient with no relevant medical history, who experienced the unexpected event of Suicidal Ideation). The event occurred approximately 1 day after the second dose of mRNA-1273 (Moderna Covid-19 vaccine). The rechallenge was not applicable as event occurred after second dose. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.   This case was linked to MOD-2021-365227 (Patient Link).; Sender's Comments: This case concerns a  62-year-old, female patient with no relevant medical history, who experienced the unexpected event of Suicidal Ideation). The event occurred approximately 1 day after the second dose of mRNA-1273 (Moderna Covid-19 vaccine). The rechallenge was not applicable as event occurred after second dose. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.
No adverse reaction at the time of injection. After given injection it was noted the patient only being 17 years old.
I am not sure that this condition is actually due to the Moderna Vaccine, but I am reporting it just in case there have been similar cases. A few weeks after the 3rd dose, I developed a  circular, itchy lesion on my chest, then I noticed several of these lesions, of various size on my back , shoulders and chest. It appears to be Pityriasis rosea which is caused by a viral infection. Don't know if there is a relation to the vaccine, but it is the only variable in my life/health.
I had cough, congestive, and very fatigue. I was in bed for 3 days. I had lost of smell. I had headache and a fever. Some of my symptoms lasted about a month. I contacted my doctor about this. I went to a urgent care to get a Covid-19 test, positive results.
Was given booster too early. Developed hived rash to entire body within 30 minutes with bloodshot eyes.
Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced FATIGUE (Fatigue). On 04-Feb-2021, FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After first dose patient had fatigue for a couple of days. Concomitant product information was not provided Treatment information was not provided   This case was linked to MOD-2021-374898, MOD-2021-374931 (Patient Link).
On August 3, 2021, I developed Supraventicular Tachycardia (SVT) and went to ER.  Released on August 4, no longer in SVT.  Returned to ER on August 5, 2021, again in SVT.  On August 6, 2021, an emergency ablation was performed at the hospital.  Released later that day (August 6, 2021).  So far, no recurrence of SVT.  I do not feel this is related to the Covid vaccine, but a repesentative from CDC suggested I enter this information for analysis, in case it was later determined to be related.
Injection site warm; Injection site hard; Itchiness at injection site; Hard lump at injection site; pink ring at injection site; left arm red at injection site; left arm puffy at injection site; pain at injection site; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard lump at injection site), VACCINATION SITE DISCOLOURATION (pink ring at injection site), VACCINATION SITE WARMTH (Injection site warm), HYPERSENSITIVITY (Itchiness at injection site) and NAUSEA (Nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced NAUSEA (Nausea) and CHILLS (Chills). On 23-Jan-2021, the patient experienced VACCINATION SITE MASS (Hard lump at injection site), VACCINATION SITE DISCOLOURATION (pink ring at injection site), VACCINATION SITE ERYTHEMA (left arm red at injection site), VACCINATION SITE SWELLING (left arm puffy at injection site) and VACCINATION SITE PAIN (pain at injection site). On 25-Jan-2021, the patient experienced HYPERSENSITIVITY (Itchiness at injection site). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE PAIN (Injection site hard). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. On 18-Jan-2021, NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 25-Jan-2021, VACCINATION SITE MASS (Hard lump at injection site), VACCINATION SITE ERYTHEMA (left arm red at injection site), VACCINATION SITE SWELLING (left arm puffy at injection site) and VACCINATION SITE PAIN (pain at injection site) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (pink ring at injection site), VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE PAIN (Injection site hard) outcome was unknown and HYPERSENSITIVITY (Itchiness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Pharmacist advised patient to treat the symptoms with ice and Diphenhydramine. No concomitant medications were reported.  The rash resolved in approximately two weeks. Patient's second dose was scheduled on 11-Feb-2021.   Most recent FOLLOW-UP information incorporated above includes: On 11-Feb-2021: Follow up received on 11 Feb 2021. Significant follow up, additional events added as injection site warm and hard.
PATIENT CALLED ON 08/12/2021 INFORMING SHE HAS AN HEADACHE EVER SINCE SHE RECEIVED THE VACCINE.
Patient reported that a his arm at the injection site was red, swollen, hot, itchy and the muscle was in  knot.  Symptoms appeared 7 days post vaccine and persisted for 5 days.
Systemic: Diarrhea-Severe, Systemic: Vomiting-Severe, Systemic: Weakness-Severe
Gave Boostrix  for ages 7 years and up instead of  Infanrix DTaP ages 6 mos to 6 yrs the appropriate vaccine for his age. The patient did not suffer any adverse symptoms. No adverse reaction occurred-discovered error when looking at billing information
17JUN96 large local rxn noted rt arm extends into inner arm skin bubbly @ site;
I have been bleeding heavily for 11 days now.; This is a spontaneous report from a contactable consumer. A 31-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in left arm on 26Apr2021 02:15 (Batch/Lot Number: EW0164) as 2nd dose, single for covid-19 immunisation. Medical history included anaemia requires iron infusions, allergies: latex, sulfa meds, penicillins, shellfish, birth control. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included prednisone (PREDNISONE) 2.5 mg daily; lamotrigine (LAMICTAL) 200 mg daily. Historical vaccine included BNT162B2 on 02Apr2021: 12:00 PM, for covid-19 immunisation, batch/lot number: EW0150, anatomical location: arm left, dose number: 1. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient stated 14 days after vaccine, I got my period for the first time in over a year. I am on birth control to help me not have them due to anemia that requires iron infusions. I have been bleeding heavily for 11 days now. Event start date was on 10May2021,12:00 PM. The patient underwent lab tests and procedures which included sars-cov-2 test: negative. Outcome was not recovered. No treatment received. Doctor or other healthcare professional office/clinic visit required.
PATIENT WAS GIVEN MODERNA VACCINE WITH AN EXPIRATION DATE OF 8/31/2021 ON 9/02/2021.
Received smallpox vaccination, 03Dec04. Over last few days has developed diffuse eruption of pustular lesions on arms, face, abdomen and back. Large lesion at site of innoculation. 25mm with multiple satellite lesions. No specific treatment. Shaving profile to minimize spread on face. F/U in 5 days or prn sooner if worse.
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Pt. came to get flu shot. Wrote on consent form allergic to eggs. signed up for FLUAD as pharmacist thought only FLUZONE HIGH DOSE was made from eggs. Pt's daughter reported to pharmacist on 10/19 regarding adverse reaction stated pt's face swelled up over night, and was still having face swelling and some tingling on face. Told patient's daughter to seek medical attention immediately, give pt. Benadryl ASAP. Only had claritin, told to take and purchase benadryl.
got sick and developed chronic illness; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration (Batch/Lot number was not reported) on an unspecified date (reported as couple of weeks ago) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, after the vaccination, the patient experienced got sick and developed chronic illness. On an unknown date, the patient underwent sars-cov-2 test which was negative. The patient is scheduled to get 2nd dose of vaccine this coming Monday or Tuesday. The outcome of the event was unknown. Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Nurse mixed flu and pneumonia vaccine in the same syringe. Before drawing up vaccines nurse dropped capped syringe on the ground and used it. Arm became red, swollen and had numbness and tingling in the fingers. Called doctor and was sent to the ER at 9 PM on Sept 4, she received IV antibiotics and then was on 2 oral antibiotics.
demyelinating polyneuropathy; bilateral carpal tunnel synd w/o axonal loss to either abdo poll brev; dx GBS versus chronic inflammatory polyneuropathy;